Comment Letters

AACC continually tracks legislative and regulatory issues of importance to clinical laboratories and the clinical laboratory profession. Recently we commented on a wide range of topics to federal and state authorities. For more information, contact AACC Government Affairs.

2016 Legislative and Regulatory Issues

AACC Endorses Restrictions on Agency Use of Guidance Documents
Nov.14.2016

AACC Recommends FDA Defer to CLIA Oversight of NGS Testing
OCT.6.2016

AACC Identifies for FDA Limits of Gene Variant Databases
OCT.6.2016

AACC Provides Input to Senate HELP Committee on LDT Regulatory Oversight
SEPT.19.2016

AACC and healthcare partners continue to pursue CDC harmonization funding
SEPT.12.2016

AACC Opposes VA Proposal to Extend Nurses Scope of Practice to Labs
JULY.22.2016

AACC urges CMS to use rulemaking process regarding CLIA equivalency for nursing degrees
JUNE.17.2016

Healthcare groups ioin AACC in support of federal funding for harmonization
MAY.27.2016

AACC urges the Senate to require FDA justification of guidance documents
MAY.19.2016

AACC urges Senate delay of LDT guidance
MAY.16.2016

AACC joins effort in support of additional funds to stop the Zika virus
MAY.13.2016

AACC submits comments to FDA regarding analytical validation of LC-MS
MAY.09.2016

AACC supports House language delaying FDA LDT guidance
MAY.04.2016

AACC provided testimony at FDA workshop on the regulation of Mass Spectrometry
MAY.02.2016

AACC joins the March of Dimes in support of emergency funding for CDC to prepare for Zika virus
APR.05.2016

AACC Provides FDA with feedback on reporting of genetic test results
MAR.28.2016

AACC Joins Friends of AHRQ to Support Restoration of Agency’s Funding
MAR.14.2016

Laboratory Community Urges Federal Funds for Harmonizing Test Results
FEB.26.2016

AACC joins Children's Health groups in raising concerns about OHRP changes to Common Rule
JAN.06.2016

AACC Opposes OHRP Limits on Use of Residual Specimens
JAN.05.2016